Dow Down 0.15% Nasdaq Down 0.11%

Enzon Pharmaceuticals, Inc. (ENZN)

-Other OTC
0.25 Down 0.01(5.16%) Apr 21, 1:13PM EDT
Prev Close:0.26
Open:0.26
Bid:0.38 x 3000
Ask:1.41 x 200
1y Target Est:14.00
Beta:0.764085
Next Earnings Date:N/A
Day's Range:0.25 - 0.26
52wk Range:0.22 - 0.53
Volume:36,434
Avg Vol (3m):79,952
Market Cap:10.88M
P/E (ttm):N/A
EPS (ttm):-0.03
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ENZN

Comparison

Symbol% ChgMkt Cap
ENZNDown 5.16%10.88M
PFEDown 0.30%200.33B
ISIS 0.00%6.91B
NKTRDown 3.97%2.83B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):1.38
Ex-Dividend Date:30-Dec-15

Analysts

Annual EPS Est () :N/A
Quarterly EPS Est () :N/A
Mean Recommendation*:1.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Enzon Pharmaceuticals, Inc. engages in licensing drug products. Its marketed drug products include PegIntron for chronic hepatitis C; Sylatron for melanoma; Macugen for neovascular (wet) age-related macular degeneration; and CIMZIA for the treatme... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback